The disclaimer at the end discloses that this analyst coverage is paid for.  I'm not familiar with how that works.  Does the company have to sign off on the details of the coverage that they are paying for?   

I feel like analysts take a conservative viewpoint for obvious reasons, but I don't think POET is being built to penetrate only a small percentage of the available market share in 1 or 2 verticles.